Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Levitsky Hyam Create: Alert

All | News | Filings
Date FiledTypeDescription
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/04/2023 4 Levitsky Hyam (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 25,200 options to buy @ $17.66, valued at $445k
04/05/2022 4 Levitsky Hyam (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 16,500 options to buy @ $18.26, valued at $301.3k
01/27/2022 4 Levitsky Hyam (President of R&D) has filed a Form 4 on Century Therapeutics, Inc.
Txns: Granted 105,000 options to buy @ $13.15, valued at $1.4M
06/17/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2020 4 Levitsky Hyam (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 16,500 options to buy @ $9.78, valued at $161.4k
04/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2018 4 Levitsky Hyam (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 27,000 options to buy @ $15, valued at $405k
07/19/2018 3 Levitsky Hyam (Director) has filed a Form 3 on Replimune Group, Inc.
02/09/2017 4 Levitsky Hyam (EVP, Research & CSO) has filed a Form 4 on Juno Therapeutics, Inc.
06/21/2016 4 Levitsky Hyam (EVP, Research & CSO) has filed a Form 4 on Juno Therapeutics, Inc.
05/27/2016 4 Levitsky Hyam (EVP, Research & CSO) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Paid exercise price by delivering 16,454 shares @ $42.04, valued at $691.7k
02/04/2016 4 Levitsky Hyam (See Remarks) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $24.5, valued at $2.5M
06/01/2015 4 Levitsky Hyam (See Remarks) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 145,000 shares @ $0
Granted 175,000 options to buy @ $50.6, valued at $8.9M
09/16/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
07/06/2011 4 Levitsky Hyam (Director) has filed a Form 4 on AGENUS INC
Txns: Granted 5,989 options to buy @ $0.897, valued at $5.4k
06/20/2011 4 Levitsky Hyam (Director) has filed a Form 4 on AGENUS INC
Txns: Granted 15,000 options to buy @ $0.81, valued at $12.2k
04/05/2011 4 Levitsky Hyam (Director) has filed a Form 4 on AGENUS INC
Txns: Granted 5,644 options to buy @ $0.952, valued at $5.4k
06/15/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
05/17/2010 4 Levitsky Hyam (Director) has filed a Form 4 on ANTIGENICS INC /DE/
Txns: Granted 15,000 options to buy @ $1.24, valued at $18.6k
06/15/2009 4 Levitsky Hyam (Director) has filed a Form 4 on ANTIGENICS INC /DE/
03/03/2009 4 Levitsky Hyam (Director) has filed a Form 4 on ANTIGENICS INC /DE/
01/05/2009 4 Levitsky Hyam (Director) has filed a Form 4 on ANTIGENICS INC /DE/

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy